Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide with rates of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) dramatically increasing. The overexpression of enhancer of zeste homolog 2 (EZH2), a histone methyltransferase responsible f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindsay, Cameron D., Kostiuk, Morris A., Harris, Jeff, O’Connell, Daniel A., Seikaly, Hadi, Biron, Vincent L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586065/
https://www.ncbi.nlm.nih.gov/pubmed/28878842
http://dx.doi.org/10.1186/s13148-017-0390-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586065/
https://www.ncbi.nlm.nih.gov/pubmed/28878842
http://dx.doi.org/10.1186/s13148-017-0390-y

Ejemplares similares